Abstract |
We examined the mechanism by which estrogen regulates telomerase activity in Caov-3 human ovarian cancer cell lines, which express ER, to determine whether the regulation affects the expression and/or phosphorylation of the telomerase catalytic subunit (hTERT). 17beta-Estradiol (E(2)) induced telomerase activity and hTERT expression. Transient expression assays using luciferase reporter plasmids containing various fragments of hTERT promoter showed that the estrogen-responsive element appeared to be partially responsible for the E(2)-induced activation of the hTERT promoter. Either pretreatment with a phosphatidylinositol 3-kinase (PI3K) inhibitor, LY294002, or transfection with a dominant-negative Akt attenuated the E(2)-induced activation of the hTERT promoter. In addition, estrogen induced the phosphorylation of IkappaB inhibitor protein via the Akt cascade, and cotransfection with a dominant-negative subunit of NFkappaB attenuated the response of the ERE-deleted hTERT promoter to E(2). Moreover, E(2) induced the phosphorylation of hTERT, the association of 14-3-3 protein and NFkappaB with hTERT, and nuclear accumulation of hTERT in an Akt-dependent manner. These results indicate that E(2) induces telomerase activity not only by transcriptional regulation of hTERT via an ERE-dependent mechanism and a PI3K/Akt/NFkappaB cascade, but also by post-transcriptional regulation via Akt-dependent phosphorylation of hTERT. Thus, the phosphorylation of Akt is a key event in the induction of telomerase activity by E(2) in human ovarian cancer cells.
|
Authors | Akiko Kimura, Masahide Ohmichi, Jun Kawagoe, Satoru Kyo, Seiji Mabuchi, Toshifumi Takahashi, Chika Ohshima, Emi Arimoto-Ishida, Yukihiro Nishio, Masaki Inoue, Hirohisa Kurachi, Keiichi Tasaka, Yuji Murata |
Journal | Oncogene
(Oncogene)
Vol. 23
Issue 26
Pg. 4505-15
(Jun 03 2004)
ISSN: 0950-9232 [Print] England |
PMID | 15048073
(Publication Type: Journal Article)
|
Chemical References |
- 14-3-3 Proteins
- Chromones
- DNA-Binding Proteins
- Enzyme Inhibitors
- Estrogens
- I-kappa B Proteins
- Morpholines
- NF-kappa B
- Phosphoinositide-3 Kinase Inhibitors
- Proto-Oncogene Proteins
- Receptors, Estrogen
- 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one
- Estradiol
- Tyrosine 3-Monooxygenase
- AKT1 protein, human
- Protein Serine-Threonine Kinases
- Proto-Oncogene Proteins c-akt
- Telomerase
|
Topics |
- 14-3-3 Proteins
- Cell Nucleus
(metabolism)
- Chromones
(pharmacology)
- DNA-Binding Proteins
- Enzyme Inhibitors
(pharmacology)
- Estradiol
(metabolism, pharmacology)
- Estrogens
(metabolism, pharmacology)
- Female
- Gene Expression Regulation, Enzymologic
- Humans
- I-kappa B Proteins
(drug effects, metabolism)
- Morpholines
(pharmacology)
- NF-kappa B
(metabolism)
- Ovarian Neoplasms
(drug therapy, metabolism)
- Phosphatidylinositol 3-Kinases
(metabolism)
- Phosphoinositide-3 Kinase Inhibitors
- Phosphorylation
- Promoter Regions, Genetic
- Protein Serine-Threonine Kinases
- Proto-Oncogene Proteins
(genetics, metabolism)
- Proto-Oncogene Proteins c-akt
- Receptors, Estrogen
(drug effects, metabolism)
- Signal Transduction
- Telomerase
(drug effects, genetics, metabolism)
- Tumor Cells, Cultured
- Tyrosine 3-Monooxygenase
(metabolism)
|